BioRestorative Therapies (BRTX) Liabilities and Shareholders Equity (2010 - 2025)
BioRestorative Therapies' Liabilities and Shareholders Equity was $4.08 million in Q4 2025, down 66.8% from $12.28 million a year earlier and down 27.7% from the prior quarter.
Powered by 
Analysis
BioRestorative Therapies (BRTX) Liabilities and Shareholders Equity (2010 - 2025) Analysis & Trends
From Q4 2010 onward, BioRestorative Therapies has reported Liabilities and Shareholders Equity for 59 quarters.
- Liabilities and Shareholders Equity has now declined for four consecutive years, with a five-year compound annual growth rate of -1.3% (FY2020 to FY2025).
- In earlier years, Liabilities and Shareholders Equity was $12.28 million in FY2024 (-2.6%), $12.61 million in FY2023 (-23.3%), $16.43 million in FY2022 (-26.8%) and $22.45 million in FY2021 (+416.5%).
- The Q4 2025 figure marks the lowest quarterly Liabilities and Shareholders Equity since Q3 2021.
- Compared with a year earlier, Liabilities and Shareholders Equity has declined for five straight quarters, with an average decline of 20.8% over the last eight quarters.
- The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q3 2022 (growth of 723.9%); the worst was Q4 2025 (a decline of 66.8%).
- Per Business Quant data, BRTX's Liabilities and Shareholders Equity in the three quarters before Q4 2025 was $5.64 million (Q3 2025), $8.52 million (Q2 2025) and $10.33 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | BioRestorative Therapies | 1.03 Mn | -22.90 Mn | 17,964.00 | 4.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 4.08 Mn |
| Sep 30, 2025 | 5.64 Mn |
| Jun 30, 2025 | 8.52 Mn |
| Mar 31, 2025 | 10.33 Mn |
| Dec 31, 2024 | 12.28 Mn |
| Sep 30, 2024 | 14.57 Mn |
| Jun 30, 2024 | 16.12 Mn |
| Mar 31, 2024 | 17.95 Mn |
| Dec 31, 2023 | 12.61 Mn |
| Sep 30, 2023 | 13.80 Mn |
| Jun 30, 2023 | 13.30 Mn |
| Mar 31, 2023 | 14.08 Mn |
| Dec 31, 2022 | 16.43 Mn |
| Sep 30, 2022 | 17.92 Mn |
| Jun 30, 2022 | 19.44 Mn |
| Mar 31, 2022 | 20.92 Mn |
| Dec 31, 2021 | 22.45 Mn |
| Sep 30, 2021 | 2.18 Mn |
| Jun 30, 2021 | 2.88 Mn |
| Mar 31, 2021 | 3.70 Mn |
API Access
BioRestorative Therapies Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();